UroGen Pharma Announces Encouraging Results from a Phase 1 Dose-Escalation Study Evaluating UGN-301 in Non-Muscle Invasive Bladder Cancer

1 week ago 14
ARTICLE AD BOX
Read Entire Article
  1. Homepage
  2. Finance
  3. UroGen Pharma Announces Encouraging Results from a Phase 1 Dose-Escalation Study Evaluating UGN-301 in Non-Muscle Invasive Bladder Cancer

Related

California Resources Q1 2025 slides: record shareholder returns amid cost structure improvements

California Resources Q1 2025 slides: record shareholder retu...

2 hours ago 0
Trimble Announces First Quarter 2025 Results

Trimble Announces First Quarter 2025 Results

2 hours ago 0
Uber Announces Results for First Quarter 2025

Uber Announces Results for First Quarter 2025

2 hours ago 0
RIGHT SIDEBAR TOP AD

Trending

1. adam schefter
2. dallas cowboys news
3. steelers news
4. brian kilmeade
5. sydney sweeney met gala 2025
6. azealia banks
7. lauryn hill met gala 2025
8. wordle may 7
9. dis stock
10. 13abc

Popular

What we know about the New York City helicopter crash that killed 6 people

What we know about the New York City helicopter crash that k...

3 weeks ago 112
Paxton's challenge isn't the only one worrying Senate Republicans

Paxton's challenge isn't the only one worrying Senate Republ...

3 weeks ago 98
Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds slim Masters lead at midway point

Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds sli...

3 weeks ago 84
Bitcoin Slips With XRP, ADA as Nvidia's Massive $5.5B Charge Sours Investor Sentiment

Bitcoin Slips With XRP, ADA as Nvidia's Massive $5.5B Charge...

3 weeks ago 82
Biden reemerges on the attack, but doesn’t mention Trump

Biden reemerges on the attack, but doesn’t mention Trump

3 weeks ago 80
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Powerbits - breaking news today 2025. All rights are reserved